Aiforia Announces a Webinar on Prognostic AI Models in Pathology
Aiforia Announces a Webinar on Prognostic AI Models in Pathology
Topic: Using Prognostic AI Models in Pathology: Case Colorectal Cancer
Date: Thursday, June 13, 2024
Time: 11am EDT / 9am MDT / 4pm BST / 5pm CEST / 6pm EEST (60 min)
Summary:
Join this webinar to discover how artificial intelligence can aid oncologists and pathologists working in the gastrointestinal field. The webinar showcases an AI model, developed by the Mayo Clinic and Aiforia, that identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for treatment decisions.
What You Will Learn:
- The current state of CRC pathology and pathologic features that guide oncologic decision-making
- How quantitative digital pathology using a digital pathology biomarker can improve risk stratification to help guide treatment and follow-up
Speakers:
Rish K. Pai, M.D., Ph.D., Pathologist, Mayo Clinic
Dr. Rish Pai earned his MD, PhD from Case Western University School of Medicine in Cleveland, OH. He completed his anatomic pathology residency at the University of Chicago Medical Center, followed by a gastrointestinal and hepatic pathology fellowship at the same institution. Dr. Pai is currently Professor of Laboratory Medicine & Pathology and serves as director of the GI/Liver service and GI/Liver fellowship at the Mayo Clinic Arizona.
Thomas Westerling-Bui, Ph.D., Chief Commercial Officer, Aiforia Inc.
Thomas Westerling-Bui is the COO, Americas at Aiforia. He received his Ph.D. in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. Thomas then completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer.
SOURCE: Aiforia
